Skip to content

Biomarkers for Post-COVID Conditions

Identification of Biomarkers for Post-COVID Conditions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05196516
Enrollment
208
Registered
2022-01-19
Start date
2022-01-13
Completion date
2022-09-23
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers, COVID-19, Post-acute COVID-19 Syndrome, SARS-CoV-2

Keywords

Post-covid-19

Brief summary

The COVID-19 infection affects humans differently. While some recover quickly and fully, others develop serious illnesses and late complications. The term late complications describe symptoms that last for 12 weeks or longer after COVID-19 infection is detected. The aim of the present project is to investigate whether it is possible to identify genetic factors that occur more frequently in people suffering from COVID-19 late complications than in those who do not develop late complications. The investigators aim to develop a genetic profile that identifies individuals at high risk for late complications of COVID-19. Number and nature of late complications will be analysed to identify patterns in the incidence of late complications associated with certain genetic traits. The study is designed as a case-control study and is expected to include 500 subjects between 18 and 65 years of age who at least 12 weeks ago tested positive for COVID-19; 250 who suffer from late complications and 250 who have fully recovered.

Interventions

None listed

Sponsors

Mental Health Services in the Capital Region, Denmark
CollaboratorOTHER
Skane University Hospital
CollaboratorOTHER
Zealand University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 65 years * SARS-CoV-2 infection proven by a PCR test at least 12 weeks prior to inclusion * Only cases: Referred to the Clinic of post-COVID conditions located in Region Zealand, Denmark

Exclusion criteria

* Need of being on a respirator during infection with SARS-CoV-2 * Only controls: complain about long covid 12 weeks or more after proven infection with SARS-CoV-2

Design outcomes

Primary

MeasureTime frameDescription
DyspneaAt inclusionMeasured by means of Medical Research Council Dyspnoea Scale (MRC), which is a single-item, rated on a 5-point likert-scale in the range 1 to 5, with higher scores indicating worse symptoms.

Secondary

MeasureTime frameDescription
Psychic stressAt inclusionMeasured by means of Kessler Psychological Distress Scale (K10), a 10-item questionnaire, scored on a 5-point Likert scale from 1 (None of the time) to 5 (All the time). The total score is in the range 10-50.
Cognitive impairmentAt inclusionMeasured by means of Montreal Cognitive Assessment (MOCA). The total score is in the range between zero and 30. A score of 26 and higher is considered normal.
Physical and mental healthAt inclusionMeasured using the 12-point Short Form Health Survey (SF-12).
Ability to copeAt inclusionMeasured by means of Coping Orientation to Problems Experienced Inventory (Brief COPE), a 28-items self-report questionnaire, scored on a 4-point Likert scale from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). The total score is in the range 28-112.
Hand grip strength (HGS)At inclusionMeasure the maximum isometric strength in the hand and forearm.
Work RehabilitationAt inclusionMeasured by means of Work Rehabilitation Questionnaire (WORQ).
Sexual function assessed by Female Sexel Function Index (FSFI_R)At inclusionMeasured by means of Female Sexel Function Index (FSFI\_R) for women. FSFI-R is a 7-item self-report questionnaire, scored on a 5-point Likert scale from 1 to 5 .
Sexual functionAt inclusionMeasured by means of International Index of Erectile Function (IIEF-5) for men . IIEF-5 is a 5-item self-report questionnaire, scored on a 5-point Likert scale from 1 to 5.
Level of Personality FunctioningAt inclusionMeasured by means of Level of Personality Functioning Scale - Brief Form (LPFS-BF), a 12-item self-report questionnaire, scored on a 4-point Likert scale from 1 (completely untrue) to 4 (completely true). The total score is in the range 12-48.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026